More Globe Newswire

View Older Stories View Newer Stories

May 5, 2026 07:05AM Aspocomp Group Plc: Notification of management’s transaction – Manu Skyttä (acquisition)
May 5, 2026 07:05AM Avista Corp. Reports Q1 2026 Financial Results, Confirms 2026 Utility Earnings Guidance
May 5, 2026 07:05AM uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
May 5, 2026 07:04AM Gilat Signs Strategic Multimillion Partnership with Nelco in India to Deploy SkyEdge IV
May 5, 2026 07:04AM YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
May 5, 2026 07:03AM Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
May 5, 2026 07:00AM Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts
May 5, 2026 07:01AM IREN Announces Acquisition of Mirantis to Strengthen AI Cloud Delivery Capabilities
May 5, 2026 07:01AM Fiserv Reports First Quarter 2026 Results
May 5, 2026 07:01AM Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026 07:00AM BrewDog Announces Partnership with Underbelly as Official Beer Supplier of Underbelly at the Edinburgh Fringe
May 5, 2026 07:00AM GlobalFoundries Reports First Quarter 2026 Financial Results
May 5, 2026 07:00AM BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026 07:00AM Virtu Financial Connects to zerohash, Further Deepening Institutional-Grade Liquidity for Digital Assets
May 5, 2026 07:00AM BellRing Brands Reports Results for the Second Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook
May 5, 2026 07:00AM Orvida Pharma to Present Functional Endpoint Development Data in Rare Palmoplantar Skin Disorders at the 83rd Annual Meeting of the Society for Investigative Dermatology and the 2026 Epidermal Differe
May 5, 2026 07:00AM Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
May 5, 2026 07:00AM Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week
May 5, 2026 07:00AM Lithium Ionic Announces Grant of Management Cease Trade Order and Status Report
May 5, 2026 07:00AM Shoals Technologies Group, Inc. Reports Financial Results for First Quarter 2026
May 5, 2026 07:00AM Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies
May 5, 2026 07:00AM Troilus Upsizes Debt Financing Mandate for up to US$1.2 Billion
May 5, 2026 07:00AM Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million
May 5, 2026 07:00AM Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference
May 5, 2026 07:00AM Body Energy Club Main Street Celebrates 6 Month Anniversary with Massive Community Appreciation Day
May 5, 2026 07:00AM National Civil Rights Museum Reopens the Legacy Experience on May 16, Marking Its 35th Anniversary and 49 Days Before America’s 250th
May 5, 2026 07:00AM Shopify Delivers Again as Merchants Clear $100 Billion in Q1 GMV
May 5, 2026 07:00AM Atea Pharmaceuticals to Host First Quarter 2026 Financial Results and Business Update Conference Call on May 12, 2026
May 5, 2026 07:00AM Sotera Health Announces Leadership Transition
May 5, 2026 07:00AM EVgo Inc. Reports First Quarter 2026 Results with Record First Quarter Revenues
May 5, 2026 07:00AM Axsome Therapeutics to Participate in Upcoming Investor Conferences
May 5, 2026 07:00AM Xali Gold Implements Baseline Studies for Drilling Permit Application at Pico Machay Gold Project in Peru
May 5, 2026 07:00AM Editas Medicine Announces First Quarter 2026 Results and Business Updates
May 5, 2026 07:00AM Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026
May 5, 2026 07:00AM Colliers Reports First Quarter Results
May 5, 2026 07:00AM Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)
May 5, 2026 07:00AM Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts
May 5, 2026 07:00AM Presenting on Emerging Growth Conference 92 Day 1 on May 6; Register to live stream
May 5, 2026 07:00AM Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
May 5, 2026 07:00AM Mike Lindell Media Corp. - LindellTV (OTC:) MLMC Announces Another Milestone as Part of the Company Short-Term Goals Strategy by Adding Sentry H20
May 5, 2026 07:00AM Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial
May 5, 2026 07:00AM OTC Markets Group Welcomes CoTec Holdings Corp. to OTCQX
May 5, 2026 07:00AM The Devon Group Names Kate Achille as Chief Executive Officer
May 5, 2026 07:00AM Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
May 5, 2026 07:00AM First Watch Restaurant Group, Inc. Reports Q1 2026 Financial Results 
May 5, 2026 07:00AM FactSet Increases Dividend
May 5, 2026 07:00AM Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
May 5, 2026 07:00AM NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine
May 5, 2026 07:00AM Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
May 5, 2026 07:00AM Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026
View Newer Stories View Older Stories